Liftstream is an executive search recruitment company in the life sciences sector
Biotech Companies Acting on Promises to Increase Racial Diversity
Biotech M&A Continues to Climb the Curve
The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field, especially as commentators were still raking over the sizable partnering deal Celgene has just cemented with Juno Therapeutics in immuno-oncology.
Posted in M&A Finance and Funding, Uncategorized Tagged Acceleron, Acetylon, Agios, AnaptysBio, AstraZeneca, Avila Therapeutics, Bay Area Cluster, Bluebirdbio, Bob Hugin, celgene, Epizyme, Immuno-Oncology, Juno Therapeutics, M&A, MedImmune, ozanimod, Receptos, Revlimid, Sutro Biopharma Leave a comment
Sutro Biopharma signs $1bn deal with Celgene
Authored by James Sheppard